Potential conflict between fundamental ethical principles and requirements of the oncology drug approval process: Ethical conflict in drug approval

Abstract

The process required to achieve federal regulatory approval of new anticancer agents has the potential to be in serious conflict with fundamental principles inherent in the ethical design of randomized controlled clinical trials.